中文产业新闻精选评分60Chinese source
默沙东 FZD4/LRP5 双抗治疗 DME 的 2b/3 期临床试验成功
默沙东：FZD4/LRP5双抗DME 2b/3期临床成功
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
默沙东：FZD4/LRP5双抗DME 2b/3期临床成功
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.